secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unity Biotechnology, Inc. (—)
CIK:        0001463361
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001193125-25-162537
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unity Biotechnology issues Series A Preferred with 600M votes to facilitate dissolution approval
--------------------------------------------------------------------------------

- Issued one Series A Preferred share to sole director Craig R. Jalbert for $1.00; share carries 600M votes, only on dissolution proposal.
- Series A votes in same proportion as common votes cast, excluding abstentions and broker non-votes, neutralizing their effect.
- Prior to issuance, dissolution required majority of outstanding common; now requires majority of voting power (common + Series A) with proportional voting.
- Series A automatically transfers back to company for no consideration upon stockholder approval of dissolution.
- Company delisted from Nasdaq on July 9, 2025; now trades OTC Pink under UNBX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1463361/000119312525162537/0001193125-25-162537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1463361/000119312525162537/d921163d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-162537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer